This inventor holds 18 USPTO granted patents and 1 published patent application. Top assignees: University of Colorado, Cortech, Inc., Nova Technology Limited Partnership. Active years: 1976-2010.
Location History:
- Blasdell, NY (US) (1995)
- Denver, CO (US) (1976 - 2010)
Company Filing History:
8 out of 1,444 
2 out of 40 
2 out of 2 
Years Active: 1976-2010
Title: John M. Stewart: Innovator in Anti-Cancer Compounds
Introduction
John M. Stewart is a prominent inventor based in Denver, CO, with a remarkable portfolio of 18 patents. His work primarily focuses on advancements in anti-cancer compounds, particularly in the field of bradykinin antagonists, which have significant implications for cancer treatment.
Latest Patents
Among his latest innovations, Stewart has developed anti-cancer compounds that provide bradykinin antagonists and pharmaceutically acceptable salts with anti-cancer activity. These compounds are notably effective in inhibiting the growth of lung and prostate cancers, showcasing their potential in enhancing cancer therapies.
Career Highlights
Throughout his career, John M. Stewart has made significant contributions to medical science and pharmacology. His affiliation with the University of Colorado has facilitated numerous research endeavors, enhancing the understanding and treatment of cancer.
Collaborations
Stewart has collaborated with esteemed colleagues such as Lajos Gera and Raymond J. Vavrek. These collaborations have bolstered his research and development projects, leading to innovative solutions in cancer treatment.
Conclusion
John M. Stewart’s dedication to innovation in anti-cancer compounds demonstrates the profound impact inventors can have on healthcare. His contributions not only advance scientific knowledge but also hold promise for improving patient outcomes in the fight against cancer.